Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) is overexpressed in a subset of human epidermal growth factor receptor 2 (HER2)-positive breast cancers, and coexpression of HER2 and EGFR has been reported to be associated with poor clinical outcome. Moreover, interaction between HER2 and EGFR ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Lee, H J, Seo, A N, Kim, E J, Jang, M H, Kim, Y J, Kim, J H, Kim, S-W, Ryu, H S, Park, I A, Im, S-A, Gong, G, Jung, K H, Kim, H J, Park, S Y
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453607/
https://ncbi.nlm.nih.gov/pubmed/25349977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.556
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados